Orientador: Stephen Hyslop / Tese (doutorado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas / Made available in DSpace on 2018-08-19T08:32:10Z (GMT). No. of bitstreams: 1 Cardoso_KiaraCarolina_D.pdf: 27750375 bytes, checksum: a1ca027909bfd58421b986e75bfcd515 (MD5) Previous issue date: 2011 / Resumo: O estudo do transcriptoma de bibliotecas de cDNA da glândula venenífera de serpentes, realizado a partir da análise de ESTs (expressed sequence tags), tem se mostrado útil na identificação de genes expressos neste tecido, inclusive no gênero Bothrops, responsável pela maioria dos acidentes ofídicos no Brasil. Neste trabalho utilizamos uma abordagem transcriptômica para analisar a composição gênica da glândula venenífera da serpente Bothrops alternatus, uma espécie encontrada no sudeste e sul do Brasil, Uruguai, norte da Argentina e leste do Paraguai. Também clonamos e caracterizamos parcialmente a enzima dipeptidilpeptidase IV (DPP IV), uma enzima que cliva peptídeos com prolina ou alanina na penúltima posição em sua porção N-terminal e que tem sido detectada em diversas peçonhas ofídicas. A construção de bibliotecas de cDNA usando métodos convencionais de clonagem, sequenciamento e análise bioinformática resultou em 5,350 ESTs que foram reunidas em 838 contigs and 4512 singletons. Pesquisas a partir de bancos de dados relevantes (BLAST) mostraram 30% de hits e 70% no-hits. Os transcritos relacionados a toxinas correspondem a 23% do total de transcritos e 78% dos hits, respectivamente. A análise por ontologia gênica (GO) detectou genes relacionados ao metabolismo geral, transcrição, tradução, processamento, degradação de polipeptídeos, funções estruturais, e regulação celular. Os principais grupos de toxinas identificados foram metaloproteinases (81%), peptídeos potenciadores da bradicinina/peptídeos natriuréticos do tipo C (8,8%), fosfolipases 'A IND. 2' ('PLA IND. 2'; 5,6%), serinoproteinases (1.9%) e lectinas do tipo C (1,5%). As metaloproteinases eram quase queexclusivamente da classe PIII, com poucas da classe PII e nenhuma da classe PI. As 'PLA IND. 2' eram todas ácidas; nenhuma 'PLA IND. 2' básica foi detectada. Outras toxinas encontradas incluíram a L-aminoácido oxidase, proteínas secretadas ricas em cisteína, DPP IV, hialuronidase, toxinas three-finger e ohanina. Foram identificadas duas proteínas não-tóxicas, a tioredoxina e a Dusp6 (fosfatase de dupla especificidade) que mostraram alto grau de similaridade a proteínas semelhantes de outras serpentes. Também foram observados polimorfismos de nucleotídeos únicos (SNPs - single-nucleotide polymorphisms), microssatélites, transposons e repetições invertidas, todos os quais podem contribuir de alguma forma para a multiplicidade de toxinas na glândula. Estes resultados mostram que a glândula venenífera de B. alternatus possui as principais classes de toxinas encontradas em estudos transcriptômicos e proteômicos de outras espécies botrópicas. ... Observação: O resumo, na íntegra, poderá ser visualizado no texto completo da tese digital / Abstract: Transcriptomic studies of snake venom gland cDNA based on the analysis of expressed sequence tags (ESTs) have been useful in identifying the genes expressed in this organ in a variety of species, including the genus Bothrops, which is responsible for most venomous snakebites in Brazil. In this work, we used a transcriptomic approach to analyze the gene composition of the venom gland of Bothrops alternatus (urutu), a species found in southeastern and southern Brazil, Uruguay, northern Argentina e eastern Paraguay. We also cloned and partially characterized dipeptidylpeptidase IV (DPP IV), an enzyme that cleaves peptides with proline or alanine as the penultimate residue in the N-terminal region and has been identified in several snake venoms. A cDNA library constructed using conventional methods of cloning, sequencing and bioinformatic analysis yielded 5,350 ESTs that formed 838 contigs and 4512 singletons. Databank BLAST searches yielded 30% hits and 70% no-hits. Toxin-related transcripts accounted for 23% of the total transcripts and 78% of the hits. Gene ontology analysis detected genes related to general metabolism, transcription, translation, processing, polypeptide degradation, structural functions and cellular regulation. The main toxin groups identified were metalloproteinases (81%), bradykinin-potentiating peptides/C-type natriuretic peptides (8.8%), phospholipases 'A IND. 2' ('PLA IND. 2'; 5.6%), serine proteinases (1.9%) and C-type lectins (1.5%). Metalloproteinases were almost exclusively class PIII, with few class PII and no class PI enzymes. The 'PLA IND. 2' were all acidic; no basic 'PLA IND. 2' were detected. Other toxins identified included L-amino acid oxidase, cysteine-rich secretory proteins, DPP IV, hyaluronidase, three-finger toxins and ohanin. Two non-toxic proteins, thioredoxin and a dual specificity phosphatase (Dusp6), shared high sequence homology with similar proteins from other snakes. Single-nucleotide polymorphisms (SNPs), microsatellites, transposons and inverted repeats were also observed and may contribute to the toxin diversity of the gland. These results show that the venom gland of B. alternatus contains the major toxin classes identified in transcriptomic and proteomic studies of other Bothrops species. The predominance of class PIII metalloproteinases agrees with the hemorrhagic activity of this venom, while the low content of serine proteinases and C-type lectins could account for the less intense coagulopathy observed after envenoming by this species. The lack of basic 'PLA IND. 2' agrees with the lower myotoxicity of this venom compared to other Bothrops species. ... Note: The complete abstract is available with the full electronic digital thesis or dissertations / Doutorado / Farmacologia / Doutor em Farmacologia

Orientador: Ronivaldo Rodrigues da Silva / Resumo: Atualmente, a avicultura é um dos setores de grande impacto na economia brasileira. Nos últimos anos, tem sido observado um aumento na produção de frangos de corte, fazendo com que este segmento da indústria gere toneladas de queratina com o descarte de penas. Isso aponta para a necessidade de degradar este material que emerge como um problema ambiental. Neste cenário, as enzimas queratinolíticas têm despertado interesse biotecnológico devido a peculiar capacidade para a degradação de queratina e a possibilidade de aplicar o hidrolisado protéico para suplementação de ração animal e uso como biofertilizantes. Desta forma, neste trabalho, nós propomos prospectar queratinases pela bactéria Citrobacter diversus e o fungo Coriolopsis byrsina e, em seguida, investigar as características bioquímicas destas enzimas, a fim de propor aplicação na degradação de penas de frango. Em nossos resultados, a bactéria C. diversus foi capaz de degradar quase completamente as penas de frango (0,5%) em meio submerso após 36 h de fermentação. O estudo com o extrato enzimático mostrou máxima atividade caseinolítica a pH 9-10,5 e 50-55 ºC, e queratinolítica a pH 8,5-9,5 e 50 ºC. Em destaque, conforme a estabilidade em incubação por 1 h a 50ºC, foi detectado aproximadamente 50% e 100% da atividade queratinolítica e caseinolítica, respectivamente. Sob estabilidade a pH por 48 h a 4ºC, o extrato enzimático manteve maior atividade na faixa de pH 6-8. A atividade caseinolítica foi inibida por EDTA e PMSF,... (Resumo completo, clicar acesso eletrônico abaixo) / Abstract: Currently, poultry is one of the sectors of great impact on the Brazilian economy. In recent years, there has been an increase in the production of broilers, causing this segment of the industry to generate tons of keratin with the disposal of feathers. This points to the need to degrade this material, which emerges as an environmental problem. In this scenario, keratinolytic enzymes have aroused biotechnological interest due to the peculiar capacity for the degradation of keratin and the possibility of applying protein hydrolyzate to supplement animal feed and use as biofertilizers. Thus, in this work we propose to prospect keratinases for the bacterium Citrobacter diversus and the fungus Coriolopsis byrsina and, next, to investigate the biochemical characteristics of these enzymes, in order to propose application in the degradation of chicken feathers. In our results, the bacterium C. diversus was able to degrade chicken feathers almost completely (0.5%) in submerged medium after 36 h. The study with the enzymatic extract showed maximum caseinolytic activity at pH 9-10.5 and 50-55 ºC, and keratinolytic activity at pH 8.5-9.5 and 50 ºC. Notably, after enzyme pre-incubation for 1 h at 50 ºC, approximately 50% and 100% of keratinolytic and caseinolytic activity were detected, respectively. Under pH stability for 48 h at 4ºC, the enzyme extract maintained greater activity in the pH 6-8 range. Caseinolytic activity was inhibited by EDTA and PMSF, and keratinolytic activity was i... (Complete abstract click electronic access below) / Mestre

A computer numerical control (CNC) apparatus was used to perform droplet centrifugation, droplet DNA extraction, and rapid droplet thermocycling on a single superhydrophobic surface and a multi-chambered PCB heater. Droplets were manipulated using "wire-guided" method (a pipette tip was used in this study). This methodology can be easily adapted to existing commercial robotic pipetting system, while demonstrated added capabilities such as vibrational mixing, high-speed centrifuging of droplets, simple DNA extraction utilizing the hydrophobicity difference between the tip and the superhydrophobic surface, and rapid thermocycling with a moving droplet, all with wire-guided droplet manipulations on a superhydrophobic surface and a multi-chambered PCB heater (i.e., not on a 96-well plate). Serial dilutions were demonstrated for diluting sample matrix. Centrifuging was demonstrated by rotating a 10 muL droplet at 2300 round per minute, concentrating E. coli by more than 3-fold within 3min. DNA extraction was demonstrated from E. coli sample utilizing the disposable pipette tip to cleverly attract the extracted DNA from the droplet residing on a superhydrophobic surface, which took less than 10min. Following extraction, the 1500bp sequence of Peptidase D from E. coli was amplified using rapid droplet thermocycling, which took 10min for 30cycles. The total assay time was 23min, including droplet centrifugation, droplet DNA extraction and rapid droplet thermocycling. Evaporation from of 10 muL droplets was not significant during these procedures, since the longest time exposure to air and the vibrations was less than 5min (during DNA extraction). The results of these sequentially executed processes were analyzed using gel electrophoresis. Thus, this work demonstrates the adaptability of the system to replace many common laboratory tasks on a single platform (through re-programmability), in rapid succession (using droplets), and with a high level of accuracy and automation.

Trypanosoma congolense is a major causative agent of the bovine disease trypanosomosis which has a considerable economic impact on sub-Saharan Africa. Current control methods for trypanosomosis are unsatisfactory and vaccine development has been hampered by antigenic variation. An anti-disease vaccine is based on the idea that disease is caused by the pathogenic factors released by the parasite, rather than by the parasite itself. Therefore, if these pathogenic factors could be neutralised by antibodies produced by vaccination, the disease could be circumvented. The method used here for identification of novel pathogenic factors is based on the concept that trypanotolerant cattle are able to mitigate the disease by generating a specific immune response against a few key antigens (pathogenic factors). Two immuno-affinity columns were therefore prepared: one containing IgG from noninfected sera and a second column containing IgG from trypanotolerant N’Dama cattle serially infected with T. congolense. The differential binding of antigens to the two columns allowed identification of antigens specifically recognised by the immune system of a trypanotolerant animal, i.e. potential pathogenic factors. The most promising antigens identified included several variant cathepsin L-like cysteine peptidases (CPs) and the Family M1 Clan MA aminopeptidases (APs). For the CPs, a study of the genetic organisation was conducted in order to further understand the variability present in this gene family. To this end, two different mini-libraries of cathepsin L-like genes were prepared: one in which genes as different as possible from congopain (the major CP of T. congolense) were selected, and a second which contained all possible genes present in the congopain array. Analysis of the sequences obtained in these two mini-libraries showed that there was significant variability of the genes within the congopain array. Two variants of CPs, chosen for differences in their catalytic triads, were cloned for expression. The recombinantly expressed CP variants differed in substrate preferences from one another and from C2 (the recombinant truncated form of congopain), and surprisingly, all enzymes were active at physiological pH. The two APs were cloned and expressed as insoluble inclusion bodies in an E. coli system, and subsequently refolded. The refolded APs showed a substrate preference for H-Ala-AMC, an optimum pH of 8.0, localisation to the cytoplasm and inhibition by puromycin. The two APs were not developmentally regulated and present in procyclic, metacyclic and bloodstream form parasites. Down-regulation of both APs by RNAi resulted in a slightly reduced growth rate in procyclic parasites in vitro. Immunisation of BALB/c mice with the APs did not provide protection when challenged with T. congolense. For an anti-disease vaccine to be protective, it would possibly have to include all pathogenic factors, including the two APs and at least one CP described in the present study. / Thesis (Ph.D.)-University of KwaZulu-Natal, Pietermaritzburg, 2010.

1. Overview Schistosomes have achieved first position among parasitic helminths, because some of them are the etiological agents of a serious human parasitic disease, schistosomiasis, which affects over 200 million people in tropical and subtropical countries (WHO, 2001). Other schistosomatids, such as the bird flukes of the genus Trichobilharzia, have also implications for human health. Although they can mature only in specific hosts (birds), their invasive larvae - cercariae - are able to penetrate also human skin due to chemical signals similar to those present on bird skin (Haas and van de Roemer 1998). Repeated infections result in an inflammatory reaction of the skin called cercarial dermatitis. Due to the increasing number of outbreaks all around the world, cercarial dermatitis is cons disease (Kolářová 2007idered as re-emerging ; Larsen et al. 2004). Among schistosomes, Trichobilharzia regenti is the only species described so far having a unique migration route within vertebrate hosts: after penetration of the skin, the invasive larvae enter peripheral nerves and continue via the spinal cord and central nervous system to the nasal cavity of birds, causing neuromotor disorders or paralyses of birds and even experimental mammals (Hrádková...

Dados recentes do nosso laboratório sugerem que a enzima dipeptidil peptidase IV (DPPIV), uma serino-protease que pode ser encontrada ancorada na membrana celular de diversos tipos celulares ou na forma solúvel no plasma, possui um papel importante na fisiopatologia da insuficiência cardíaca (IC). Mais especificamente, demonstramos que a atividade da DPPIV circulante está associada com piores desfechos cardiovasculares em modelo experimental e pacientes com IC. Ademais, observamos que a inibição crônica da DPPIV atenua o desenvolvimento e/ou a progressão da IC em ratos submetidos à injúria do miocárdio. Entretanto, não é sabido se a inibição desta peptidase é capaz de reverter a disfunção cardiorrenal em ratos com IC estabelecida. Assim, este trabalho teve como objetivo testar a hipótese que a inibição da DPPIV exerce efeitos terapêuticos em ratos com IC. Para tal, ratos com IC foram tratados diariamente com o inibidor da DPPIV Vildagliptina (80 ou 120 mg/kg/dia) ou veículo (HF) durante quatro semanas. Ratos Sham não-tratados foram utilizados como controle. Análises ecocardiográficas demonstraram que ratos HF exibiram área fracional (FAC) menor e tempo de relaxamento isovolumétrico (TRIV) maior que ratos Sham. Por sua vez, o tratamento com a dose maior de Vildagliptina foi capaz de aumentar a FAC e diminuir o TRIV. Esta melhora funcional foi acompanhada por melhoras estruturais, visto que a inibição da DPPIV foi capaz de reduzir a hipertrofia cardíaca e a deposição de colágeno intersticial no miocárdio remanescente de ratos tratados com Vildagliptina em comparação aos ratos HF. Adicionalmente, ratos com IC exibiram maior teor de água nos pulmões, menor excreção urinária de sódio, menor fluxo urinário e menor ritmo de filtração glomerular em comparação ao grupo Sham. Por sua vez, o manuseio renal de sal e água foi completamente restaurado pelo tratamento crônico com 120 mg/kg/dia Vildagliptina. A normalização da função renal induzida pela inibição crônica da DPPIV foi associada com um aumento da expressão do receptor do peptídeo-1 semelhante ao glucagon (GLP-1) e maior ativação da proteína cinase A em córtex renal, isto é, da via de sinalização deflagrada pela ligação GLP-1/GLP-1R. Além disso, os níveis pós-prandiais do GLP-1, principal substrato da DPPIV que exerce ações insulinotrópicas, cardio e renoprotetoras, estavam mais baixos em ratos HF que em ratos Sham. Esta diminuição dos níveis circulantes de GLP-1 (ativo e total) em ratos HF foi acompanhada de intolerância à glicose bem como de maiores níveis plasmáticos de insulina. A inibição da DPPIV com Vildagliptina melhorou a biodisponibilidade e a secreção de GLP-1 após carga oral de glicose. Em conjunto, estes resultados sugerem que a inibição da DPPIV melhora a função cardiorrenal e metabólica de ratos com IC. Além disso, a secreção e a biodisponibilidade do GLP-1 encontram-se prejudicadas em ratos com IC e o tratamento com Vildagliptina é capaz de restaurar a sinalização mediada por este peptídeo. Assim, os inibidores da DPPIV podem ser eficazes não apenas para a prevenção, mas também para o tratamento da insuficiência cardíaca em ratos / Recent data from our laboratory suggest that the enzyme dipeptidyl peptidase IV (DPPIV), a serine protease that can be found anchored in the cell membrane of different cell types or in the soluble form in plasma, plays an important role in the pathophysiology of heart failure (HF). More specifically, we have demonstrated that the activity of circulating DPPIV is associated with poorer cardiovascular outcomes in an experimental model and patients with HF. In addition, we have found that chronic inhibition of DPPIV attenuates the development and/or progression of HF in rats with myocardial injury. However, it is unknown whether the inhibition of this peptidase is able to reverse the cardiorenal dysfunction in rats with established HF. Therefore, this study aimed to test the hypothesis that inhibition of DPPIV exerts therapeutic effects in rats with HF. To this end, HF rats were treated daily with the DPPIV inhibitor vildagliptin (80 or 120 mg/kg/day) or vehicle (HF) for four weeks. Untreated Sham rats were used as controls. Echocardiographic analysis demonstrated that HF rats exhibit lower fractional area change (FAC) and higher isovolumetric relaxation time (IVRT) than Sham rats. On the other hand, treatment with the highest dose of vildagliptin was able to increase FAC and decrease IVRT. These functional improvements were accompanied by structural improvements, since inhibition of DPPIV was also able to reduce cardiac hypertrophy and interstitial collagen deposition in the remaining myocardium of rats treated with vildagliptin rats compared to HF. In addition, HF rats exhibited higher water content in the lungs, lower urinary sodium excretion, lower urinary flow and lower glomerular filtration rate compared to the Sham group. In turn, the renal handling of salt and water was completely restored by chronic treatment with vildagliptin 120 mg/kg/day. Normalization of the renal function induced by chronic inhibition of DPPIV was associated with an increase in the expression of the glucagon like peptide-1 receptor (GLP-1R) and enhanced protein kinase A activation in the renal cortex, the signaling pathway triggered by bind between GLP-1/GLP-1R. In addition, the postprandial levels of GLP-1, the main substrate of DPPIV that exerts insulinotropic, cardio and renoprotective actions, were lower in HF rats than in Sham. This decrease in circulating levels of GLP-1 (active and total) in HF rats was accompanied by impaired glucose tolerance and higher plasma insulin levels. The inhibition of the DPPIV with vildagliptin improved the bioavailability and secretion after an oral glucose load. Taken together, these results suggest that the inhibition of DPPIV ameliorates the cardiorenal and metabolic function of rats with HF. Furthermore, bioavailability and secretion of GLP-1 are impaired in HF rats and vildagliptin is able to restore the signaling mediated by this peptide. Therefore, DPPIV inhibitors can be effective not only in preventing but also for the treatment of HF in rats

Foram analisados alguns parâmetros que influenciam os bioprocessos, submerso e sólido, do fungo Eupenicillium javanicum na produção de peptidases. No bioprocesso submerso foram avaliados a influência de diferentes concentrações e tipos de fonte de carbono e concentrações de fonte nitrogênio no meio, pH, temperatura e tempo de incubação. No bioprocesso sólido avaliou-se a influência de dois tipos de resíduos agroindustriais, em diferentes proporções, dois tipos de fonte de nitrogênio, em diferentes concentrações, tempo e temperatura de incubação. As peptidases produzidas em ambos os bioprocessos foram caracterizadas bioquimicamente, avaliando pH e temperatura ótima, estabilidade em diferentes temperaturas e valores de pH e influência da adição de íons e inibidores na atividade da peptidase. A enzima produzida em bioprocesso sólido foi submetida ao processo de purificação utilizando métodos cromatográficos. Utilizando a peptidase pura realizou-se a caracterização bioquímica funcional e a determinação dos parâmetros cinéticos, ambos utilizando o substrato peptídico de supressão intramolecular de fluorescência. Além disso, o extrato enzimático obtido através do bioprocesso foi submetido ao processo de microencapsulação, visando uma maior estabilidade das peptidases e facilidade no armazenamento e transporte, utilizando a técnica de Spray drying, em seguida foi avaliado o rendimento do processo e a estabilidade das peptidases das micropartículas produzidas. O fungo Eupenicillium javanicum mostrou potencial na produção de peptidases em ambos bioprocessos, produzindo peptidases da classe das metalopeptidases com alta estabilidade em diferentes valores de pH e temperatura. O processo de purificação mostrou-se viável e reprodutível. A análise dos parâmetros cinéticos revelou uma grande influência do lado \"linha\" da peptidase na eficiência catalítica. O processo de microencapsulação mostrou-se viável e gerou micropartículas estáveis. A peptidase produzida apresentou características que demonstram seu potencial uso nas diferentes áreas industriais. / Some parameters that influence the submerged and semi solid bioprocesses, by the fungus Eupenicillium javanicum in the peptidases production, were conducted. In submerged bioprocess was evaluated the effect of different concentrations and types of carbon source and nitrogen source in the medium, pH, temperature and incubation time. In semi solid bioprocess semi solid was evaluated the influence of two types of agroindustrial residues, in different proportions, and different concentrations of nitrogen source, temperature and of incubation time. The peptidases produced in both bioprocesses were characterized biochemically, evaluating, the optimum pH and temperature, stability at different temperatures and pH values and the influence of the addition of ions and inhibitors on peptidase activity. The enzyme produced in semi solid bioprocess was subjected to the purification process using chromatographic methods. Using pure peptidase was performed the biochemical characterization and determination of kinetic parameters, both using the fluorescence intramolecular suppression peptide substrate. Furthermore, the enzymatic extract obtained by semi solid bioprocess was subjected to microencapsulation process by using the technique of spray drying, in order to obtain greater stability, ease storage and transport of peptidases, then assessed the yield process and stability of the peptidases of microparticles produced. The fungus Eupenicillium javanicum showed potential production of peptidases in the both bioprocesses, producing peptidases that belong to the class of metallopeptidases, with high stability at different pH and temperature. The purification process was feasible and reproducible. The analysis of kinetic parameters revealed a strong influence of the \"line\" side on the peptidase catalytic efficiency. The microencapsulation process was feasible and generated stable microparticles. The peptidase produced has characteristics that demonstrated it a potential use in different industrial fields.

Made available in DSpace on 2014-06-11T19:30:54Z (GMT). No. of bitstreams: 0 Previous issue date: 2005-08-11Bitstream added on 2014-06-13T19:40:24Z : No. of bitstreams: 1 cabral_h_dr_sjrp.pdf: 2111647 bytes, checksum: 119e7754b951e76b7b463f93125a12db (MD5) / Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) / As peptidases ou proteases hidrolisam ligações peptídicas. Apesar de todas terem essa característica funcional comum, elas diferem acentuadamente no seu grau de especificidade. O conhecimento da especificidade das cisteíno-peptidase, nos fornece valiosas informações que podem levar a uma melhor compreensão da relação estrutura-função, do papel fisiológico destas enzimas, ou para o desenho de inibidores seletivos. Pela caracterização realizada, a Fastuosaina, uma cisteíno peptidase extraída de frutos verdes de gravatá (Bromelia fastuosa) possui um pH ótimo próximo do neutro, semelhante à Bromelina do talo e do fruto, por enquanto para a Papaína, que possui um pH ótimo de 6,3. Em relação à estabilidade térmica, a Fastuosaina mostrou ser mais resistente à desnaturação, seguida pela Papaína, a Bromelina do fruto e por último a Bromelina do talo. / Peptidases, also known as proteases, hydrolyse peptide bonds with different specificities. Knowing their preferences for cleavage sites, gives valuable informations that can lead to a better understanding of the structure-function relationships, their physiological role, or for design of selective inhibitors. We performed a characterization of Fastuosain, a cystein-peptidase isolated from unripe fruits of gravatá (Bromelia fastuosa), which showed an optimum pH near 7.0, as found also for stem and fruit bromelains. Papain showed a lower value, at pH 6.3. Concerning its thermal stability, Fastuosain showed higher resistance to denaturation, followed by Papain, Fruit and Stem Bromelain.

Dados recentes do nosso laboratório sugerem que a enzima dipeptidil peptidase IV (DPPIV), uma serino-protease que pode ser encontrada ancorada na membrana celular de diversos tipos celulares ou na forma solúvel no plasma, possui um papel importante na fisiopatologia da insuficiência cardíaca (IC). Mais especificamente, demonstramos que a atividade da DPPIV circulante está associada com piores desfechos cardiovasculares em modelo experimental e pacientes com IC. Ademais, observamos que a inibição crônica da DPPIV atenua o desenvolvimento e/ou a progressão da IC em ratos submetidos à injúria do miocárdio. Entretanto, não é sabido se a inibição desta peptidase é capaz de reverter a disfunção cardiorrenal em ratos com IC estabelecida. Assim, este trabalho teve como objetivo testar a hipótese que a inibição da DPPIV exerce efeitos terapêuticos em ratos com IC. Para tal, ratos com IC foram tratados diariamente com o inibidor da DPPIV Vildagliptina (80 ou 120 mg/kg/dia) ou veículo (HF) durante quatro semanas. Ratos Sham não-tratados foram utilizados como controle. Análises ecocardiográficas demonstraram que ratos HF exibiram área fracional (FAC) menor e tempo de relaxamento isovolumétrico (TRIV) maior que ratos Sham. Por sua vez, o tratamento com a dose maior de Vildagliptina foi capaz de aumentar a FAC e diminuir o TRIV. Esta melhora funcional foi acompanhada por melhoras estruturais, visto que a inibição da DPPIV foi capaz de reduzir a hipertrofia cardíaca e a deposição de colágeno intersticial no miocárdio remanescente de ratos tratados com Vildagliptina em comparação aos ratos HF. Adicionalmente, ratos com IC exibiram maior teor de água nos pulmões, menor excreção urinária de sódio, menor fluxo urinário e menor ritmo de filtração glomerular em comparação ao grupo Sham. Por sua vez, o manuseio renal de sal e água foi completamente restaurado pelo tratamento crônico com 120 mg/kg/dia Vildagliptina. A normalização da função renal induzida pela inibição crônica da DPPIV foi associada com um aumento da expressão do receptor do peptídeo-1 semelhante ao glucagon (GLP-1) e maior ativação da proteína cinase A em córtex renal, isto é, da via de sinalização deflagrada pela ligação GLP-1/GLP-1R. Além disso, os níveis pós-prandiais do GLP-1, principal substrato da DPPIV que exerce ações insulinotrópicas, cardio e renoprotetoras, estavam mais baixos em ratos HF que em ratos Sham. Esta diminuição dos níveis circulantes de GLP-1 (ativo e total) em ratos HF foi acompanhada de intolerância à glicose bem como de maiores níveis plasmáticos de insulina. A inibição da DPPIV com Vildagliptina melhorou a biodisponibilidade e a secreção de GLP-1 após carga oral de glicose. Em conjunto, estes resultados sugerem que a inibição da DPPIV melhora a função cardiorrenal e metabólica de ratos com IC. Além disso, a secreção e a biodisponibilidade do GLP-1 encontram-se prejudicadas em ratos com IC e o tratamento com Vildagliptina é capaz de restaurar a sinalização mediada por este peptídeo. Assim, os inibidores da DPPIV podem ser eficazes não apenas para a prevenção, mas também para o tratamento da insuficiência cardíaca em ratos / Recent data from our laboratory suggest that the enzyme dipeptidyl peptidase IV (DPPIV), a serine protease that can be found anchored in the cell membrane of different cell types or in the soluble form in plasma, plays an important role in the pathophysiology of heart failure (HF). More specifically, we have demonstrated that the activity of circulating DPPIV is associated with poorer cardiovascular outcomes in an experimental model and patients with HF. In addition, we have found that chronic inhibition of DPPIV attenuates the development and/or progression of HF in rats with myocardial injury. However, it is unknown whether the inhibition of this peptidase is able to reverse the cardiorenal dysfunction in rats with established HF. Therefore, this study aimed to test the hypothesis that inhibition of DPPIV exerts therapeutic effects in rats with HF. To this end, HF rats were treated daily with the DPPIV inhibitor vildagliptin (80 or 120 mg/kg/day) or vehicle (HF) for four weeks. Untreated Sham rats were used as controls. Echocardiographic analysis demonstrated that HF rats exhibit lower fractional area change (FAC) and higher isovolumetric relaxation time (IVRT) than Sham rats. On the other hand, treatment with the highest dose of vildagliptin was able to increase FAC and decrease IVRT. These functional improvements were accompanied by structural improvements, since inhibition of DPPIV was also able to reduce cardiac hypertrophy and interstitial collagen deposition in the remaining myocardium of rats treated with vildagliptin rats compared to HF. In addition, HF rats exhibited higher water content in the lungs, lower urinary sodium excretion, lower urinary flow and lower glomerular filtration rate compared to the Sham group. In turn, the renal handling of salt and water was completely restored by chronic treatment with vildagliptin 120 mg/kg/day. Normalization of the renal function induced by chronic inhibition of DPPIV was associated with an increase in the expression of the glucagon like peptide-1 receptor (GLP-1R) and enhanced protein kinase A activation in the renal cortex, the signaling pathway triggered by bind between GLP-1/GLP-1R. In addition, the postprandial levels of GLP-1, the main substrate of DPPIV that exerts insulinotropic, cardio and renoprotective actions, were lower in HF rats than in Sham. This decrease in circulating levels of GLP-1 (active and total) in HF rats was accompanied by impaired glucose tolerance and higher plasma insulin levels. The inhibition of the DPPIV with vildagliptin improved the bioavailability and secretion after an oral glucose load. Taken together, these results suggest that the inhibition of DPPIV ameliorates the cardiorenal and metabolic function of rats with HF. Furthermore, bioavailability and secretion of GLP-1 are impaired in HF rats and vildagliptin is able to restore the signaling mediated by this peptide. Therefore, DPPIV inhibitors can be effective not only in preventing but also for the treatment of HF in rats

Les DD-peptidases sont des enzymes impliquées dans la synthèse de la paroi bactérienne. Elles sont aussi appelées "Penicillin Binding Proteins" (PBPs) car elles forment des acyl-enzymes stables avec des antibiotiques de type beta-lactames comme la pénicilline, la stabilité de ces complexes étant à l'origine de l'effet antibiotique. Certaines bactéries sont résistantes aux b-lactames grâce à la production de beta-lactamases, capables d'hydrolyser ces antibiotiques jusqu'à 10E8 fois plus rapidement que les PBPs selon un mécanisme impliquant deux étapes, d'acylation puis de désacylation. Il est généralement accepté que les beta-lactamases ont évolué à partir d'une PBP ancestrale en intégrant au site actif un mécanisme catalytique efficace pour la réaction de déacylation. L'objectif de cette thèse s'inscrit dans la compréhension des mécanismes d'évolution de la catalyse enzymatique au niveau moléculaire. Nous tenterons de reproduire un mécanisme évolutif en créant in vitro une activité b-lactamase à partir d'une DD-peptidase. La protéine de départ pour ce travail est la PBP-A de Thermosynechococcus elongatus, appartenant à une nouvelle famille de PBPs homologue aux beta-lactamases de classe A. L'analyse biochimique de cette protéine suggère que c'est une DD-peptidase, et une approche rationnelle par substitution d'un résidu dans le site actif de PBP-A a permis d'augmenter la vitesse de désacylation de l'acyl-enzyme formé avec la pénicilline d'un facteur 90. L'analyse des structures 3-D de PBP-A sauvage et mutante laisse ouverte la question de savoir comment évoluer cette PBP en beta-lactamase. Ainsi, pour l'évolution dirigée de cette protéine, deux banques ont été construites par approches aléatoire et semi-rationnelle. Il a été possible de sélectionner par "phage display" des enzymes améliorées pour la réaction d'acylation. L'obtention de mutants améliorés pour l'acylation ou la désacylation constitue des premiers pas vers l'évolution de PBP-A en beta-lactamase.